1. Home
  2. BCRX vs AI Comparison

BCRX vs AI Comparison

Compare BCRX & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$7.89

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo C3.ai Inc.

AI

C3.ai Inc.

HOLD

Current Price

$12.79

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
AI
Founded
1986
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
BCRX
AI
Price
$7.89
$12.79
Analyst Decision
Buy
Sell
Analyst Count
11
13
Target Price
★ $20.55
$8.90
AVG Volume (30 Days)
★ 4.7M
4.7M
Earning Date
11-04-2026
12-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 381.40
N/A
EPS
N/A
★ N/A
Revenue
$25,186,000.00
★ $250,268,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.71
$10.28
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.23
$7.68
52 Week High
$11.22
$18.64

Technical Indicators

Market Signals
Indicator
BCRX
AI
Relative Strength Index (RSI) 42.17 69.52
Support Level $6.35 $9.86
Resistance Level $9.22 $14.20
Average True Range (ATR) 0.30 0.66
MACD 0.00 0.10
Stochastic Oscillator 33.49 93.99

Price Performance

Historical Comparison
BCRX
AI

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About AI C3.ai Inc.

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions, namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications; C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications; and C3 Generative AI, which combines the utility of large language models. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.

Share on Social Networks: